• Galectin Therapeutics (NASDAQ:GALT) Earns Neutral Rating from HC Wainwright

    Source: Buzz FX / 27 Dec 2024 12:46:13   America/New_York


    Galectin Therapeutics (NASDAQ:GALT) Earns Neutral Rating from HC Wainwright Written by MarketBeat December 27, 2024 Share Link copied to clipboard. Galectin Therapeutics ( NASDAQ:GALT - Get Free Report ) 's stock had its "neutral" rating re
    Read more...
Share on,